Design and characterization of nano sponges loaded vaginal gels of Voriconazole
DOI:
https://doi.org/10.34117/bjdv10n1-024Keywords:
Voriconazole, nano sponges, mucoadhesive, vaginal gelsAbstract
Objectives: The current inquiry of this research job is to build and analyze a bio adhesive vaginal gel that is packed with Voriconazole Nano sponge for an extended residence duration at the point of infection, resulting in a positive drug release profile. Methods: Nano sponges were created using a solvent evaporation process in varied Voriconazole to β-cyclodextrin ratios. Zeta possibility, polydispersity, size of particles analysis, capture efficiency, and surface morphology of Nao sponges are all determined using scanning microscopes with electrons (SEM). FTIR and DSC investigations were used to determine drug excipient compatibility. Carbopol/Hypromellose/Sodium Carboxymethyl cellulose/HPC has been used to make the bio adhesive gel, while both propyl paraben and a methyl para were employed as antioxidants. Triethanolamine, also was used to regulate the pH, resulting in a transparent gel. The gel base has been incorporated with the improved Voriconazole Nano sponge mixture. The pH, viscosity, spread ability, extrudability, and medication content of Nano sponge in mixes of gels were all investigated. The gel's in vivo diffusion has been examined on goat vaginal mucosal. Cellophane membranes was used in an artificial drug release examination. Results: The improved generation of IDLNS12 Nano sponge (drug-polymer ratio 1:1) demonstrated 91.56% entrapment efficiency. The average particle diameter of all formulations was less than 310 nm. The SEM photographs revealed smooth and spherical particles. INSG4 (Carpool and HPC) gel formulation had a viscosity value of 4529 cps at 2-10 RPM, a gel strength of 92.65N load, and an expansion speed of 37.24 g.cm/seconds. At 12.0 minutes, INSG4 achieved 99.98% drug release. And a mucous adhesive time of in excess of 12 hours. Conclusion: These results suggest that Voriconazole-loaded β-cyclodextrin Nano sponge in mucous adhesive gel might be used for managing infections of vagina perpetually.
References
Qaiser M, Shahzad Q, Hamza M and Hussain S. Antifungal Drugs Loaded Nanosponges to Improve Bioavailability of Antifungal Drugs; A Review. Pharm Res 2021, 5(4): 000255.
Balasaheb M, Patil MP, Jahagirdar AC, Khandekar BD (2015) Nanosponge An emerging drug delivery system. International Journal of Institutional Pharmacy and Life Sciences 5(6): 160-174. 34.
Ahmed RZ, Patil G, Zaheer Z (2013) Nanosponges–a completely new nano-horizon: pharmaceutical applications and recent advances. Drug Dev Ind Pharm 39(9): 1263-1272. 35.
Tejashri G, Amrita B, Darshana J (2013) Cyclodextrin based nanosponges for pharmaceutical use: A review. Acta Pharm 63(3): 335-358. 36. Ghose A, Nabi B, Rehman S
Sanati, H.; Belanger, P.; Fratti, R.; Ghannoum, M. A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in candida albicans and candida krusei. Antimicrob. Agents Chemother. 1997, 41, 2492–2496.
Kumar, S.S.; Thakuria, R.; Nangia, A. Pharmaceutical cocrystals and a nitrate salt of voriconazole. CrystEngComm 2014, 16, 4722.
Monica R, Amrita B, Ishwar K, Ghanshyam M and Trotta F. In vitro and in vivo evaluation of β-cyclodextrin-basednanosponges of telmisartan. J Incl Phenom Macrocycl Chem. (2012), 1-11.
Rakesh P, Hardik H and Ashok H B. Formulation and evaluation of carbopol gel containing liposomes of ketoconazole (Part-II). Int J Drug Deli Tech. (2009), 1(2): 42 – 45.
Sharma R, Roderick B and Pathak K. Evaluation of kinetics and mechanism of drug release from Econazole nitrate Nanosponge loaded carbopol Hydrogel. Indian J of Pharma Edu and res. (2011), 45(1):25-31.
Dr.Prathima Srinivas, Sreeja. K. Formulation and Evaluation of Voriconazole Loaded Nanosponges for Oral and Topical Delivery. Int. J. Drug Dev. & Res., 2013, 5(1): 55-69
Shankar S, Vavia P R, Francesco T and Satyen T. Formulation of β-cyclodextrin based nanosponges of Miconazole nitrate. J Incl Phenom Macrocycl Chem. (2007), 57: 89–94.
Swaminathan S, Pradeep R Vavia, Francesco T, Cavalli R, Simonetta T and Luca B. Structural evidence of differential forms of nanosponges of β-cyclodextrin and its effect on solubilization of a model drug. J Incl Phenom Macrocycl Chem. (2013), 76(1-2): 201-11.
Shankar S, Linda P, Loredana S, Francesco T, Pradeep V, Dino A, Michele T, Gianpaolo Z and Roberta C. Cyclodextrin-based nanosponges encapsulating camptothecin: Physicochemical characterization, stability and cytotoxicity. Eur J Pharm Biopharm. (2010), 74: 193-201.
Cavalli R, Trotita F and Tumiatti W. Cyclodextrin-based nanosponges for drug delivery. J of Inclusion Phenomena and Macro Chem. (2006), 56 (1-2): 209-213.
Jilsha G and Vidya Vi. Nanosponges: A novel approach of drug delivery system Int. J. Pharm. Sci. Rev. Res. (2013), 19(2): 119-123.
Loganathan V, Manimaran S, Sulaiman A, Reddy M V S, Senthil B K and Rajaseskar A. The effects of polymers and permeation enhancers on releases of flurbiprofen from gel formulations. IndJof Pharmaceutical Sci. (2001), 63(3): 200-4.
Jain V and Singh R. Dicyclomine-loaded Eudragit®-based microsponge with potential for colonic delivery: preparation and characterization. Tropical J of Pharmaceutical Res. (2010), 9(1): 67-72.
Niyogi P, Raju N J, Reddy P G and Rao B G. Formulation and evaluation of antiinflammatory activity of solanum pubescens wild extracts gel on albino wistar rats. Int J of pharmacy 2012. 2(3). 484-490.
Rakesh P, Hardik H P and Ashok H b. Formulation and evaluation of carbopol gel containing liposomes of ketoconazole (Part-II). Int J Drug Deli Tech. (2009), 1(2): 42 – 45.
Esposito E, Ravani L Contado C, Costenaro A Drechsler M and Rossi D. Clotrimazole nanoparticle gel for mucosal administration. Materials Sci and Eng. (2013), C33: 411–8.
Prathima S and Sreeja. K. Formulation and Evaluation of Voriconazole Loaded Nanosponges for Oral and Topical Delivery. Int. J. Drug Dev. & Res. (2013), 5(1): 55-69.
Sakarkar D M and Shrikhande V N. Studies on formulation development, characterization and transdermal permeation of nimesulide from emulgel. Int. J. Pharma. Excip. (2004),3(3): 57-61.
